These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11388817)

  • 1. The incidence of unrecognized myocardial infarction in women with coronary heart disease.
    Shlipak MG; Elmouchi DA; Herrington DM; Lin F; Grady D; Hlatky MA;
    Ann Intern Med; 2001 Jun; 134(11):1043-7. PubMed ID: 11388817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
    N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
    Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
    Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
    Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).
    Cauley JA; Black DM; Barrett-Connor E; Harris F; Shields K; Applegate W; Cummings SR
    Am J Med; 2001 Apr; 110(6):442-50. PubMed ID: 11331055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
    Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA;
    JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).
    Sawaya GF; Grady D; Kerlikowske K; Valleur JL; Barnabei VM; Bass K; Snyder TE; Pickar JH; Agarwal SK; Mandelblatt J
    Ann Intern Med; 2000 Dec; 133(12):942-50. PubMed ID: 11119395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.
    Herrington DM; Reboussin DM; Klein KP; Sharp PC; Shumaker SA; Snyder TE; Geisinger KR
    Control Clin Trials; 2000 Jun; 21(3):257-85. PubMed ID: 10822123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.
    Hall G; Pripp U; Schenck-Gustafsson K; Landgren BM
    Maturitas; 1998 Jan; 28(3):235-42. PubMed ID: 9571599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
    Grady D; Wenger NK; Herrington D; Khan S; Furberg C; Hunninghake D; Vittinghoff E; Hulley S
    Ann Intern Med; 2000 May; 132(9):689-96. PubMed ID: 10787361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summaries for patients. Unrecognized heart attacks in women with known coronary artery disease.
    Ann Intern Med; 2001 Jun; 134(11):S-11. PubMed ID: 11396432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.